Currently out of the existing stock ratings of Ralph Giacobbe, 82 are a HOLD (32.28%), 168 are a BUY (66.14%), 4 are a SELL (1.57%).

Ralph Giacobbe

Work Performance Price Targets & Ratings Chart

Analyst Ralph Giacobbe, carries an average stock price target met ratio of 80.67% that have a potential upside of 23% achieved within 247 days. Previously, Ralph Giacobbe worked at CITI.

Ralph Giacobbe’s has documented 465 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on DGX, Quest Diagnostics at 10-Jul-2024.

Wall Street Analyst Ralph Giacobbe

Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for APR (APRIA) at 5/17/2021. The price target of $33 was fulfilled within 4 days with a profit of $3.69 (12.59%) receiving and performance score of 31.47.

Average potential price target upside

of $65.39 (20.01%) on HUM (HUMANA).
of $65.25 (26.53%) on ELV (ELEVANCE HEALTH).
of $63.05 (36.08%) on CI (CIGNA CORP).

ACHC Acadia Healthcare Company ANTM Anthem APR Apria BHG Bright Health Group CI Cigna Corp CLOV Clover Health Investments Corp CNC Centene Corp CVS CVS Health Corp CYH Community Health Systems DGX Quest Diagnostics EVHC Envision Healthcare Holdings HCA HCA Holdings HUM Humana LH Laboratory of America Holdings MD Mednax ONEM 1Life Healthcare PGNY Progyny SGRY Surgery Partners THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group WBA Walgreens Boots Alliance AGTI Agiliti INNV InnovAge Holding Corp CANO Cano Health ELV Elevance Health

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Andrew Mok (BARCLAYS)